CH Biotech Ser Releases Circular Detailing Major Disposal of PHC Medical Diagnostic Centre and Premier Medicare Stakes

Bulletin Express

Jun 30

China Biotech Services Holdings Limited (abbreviated as CH Biotech Ser) has published a bilingual circular dated 30 June 2026 outlining a major transaction involving the disposal of 100% of the issued share capital of two subsidiaries—PHC Medical Diagnostic Centre Limited and Premier Medicare Services Limited.

The circular, now available on both the company’s website (www.cbshhk.com) and the Hong Kong Stock Exchange’s website (www.hkexnews.hk), provides shareholders with full details of the planned divestment. The transaction has been classified as “major” under the Hong Kong Listing Rules, indicating that it meets or exceeds the applicable percentage ratio thresholds for significant corporate actions.

Non-registered shareholders may request hard copies of the circular free of charge by contacting the company’s Hong Kong branch share registrar, Union Registrars Limited, at Suites 3301-04, 33/F, Two Chinachem Exchange Square, 338 King’s Road, North Point, Hong Kong, or via email at 8037-corpcomm@unionregistrars.com.hk. Shareholders opting for electronic communications can provide their email addresses through their respective banking or brokerage intermediaries to receive future notices electronically.

Enquiries regarding the document or the distribution arrangement can be directed to Union Registrars Limited at (+852) 2849 3399 during business hours, Monday to Friday (excluding Hong Kong public holidays).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/news/1198160072"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1198160072\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1198160072?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-30 21:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1198160072","market":"hk","top_or_hot":-1,"title":"CH Biotech Ser Releases Circular Detailing Major Disposal of PHC Medical Diagnostic Centre and Premier Medicare Stakes","media":"Bulletin Express","content":"<p>China Biotech Services Holdings Limited (abbreviated as CH Biotech Ser) has published a bilingual circular dated 30 June 2026 outlining a major transaction involving the disposal of 100% of the issued share capital of two subsidiaries—PHC Medical Diagnostic Centre Limited and Premier Medicare Services Limited.</p>\n<p>The circular, now available on both the company’s website (www.cbshhk.com) and the Hong Kong Stock Exchange’s website (www.hkexnews.hk), provides shareholders with full details of the planned divestment. The transaction has been classified as “major” under the Hong Kong Listing Rules, indicating that it meets or exceeds the applicable percentage ratio thresholds for significant corporate actions.</p>\n<p>Non-registered shareholders may request hard copies of the circular free of charge by contacting the company’s Hong Kong branch share registrar, Union Registrars Limited, at Suites 3301-04, 33/F, Two Chinachem Exchange Square, 338 King’s Road, North Point, Hong Kong, or via email at 8037-corpcomm@unionregistrars.com.hk. Shareholders opting for electronic communications can provide their email addresses through their respective banking or brokerage intermediaries to receive future notices electronically.</p>\n<p>Enquiries regarding the document or the distribution arrangement can be directed to Union Registrars Limited at (+852) 2849 3399 during business hours, Monday to Friday (excluding Hong Kong public holidays).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CH Biotech Ser Releases Circular Detailing Major Disposal of PHC Medical Diagnostic Centre and Premier Medicare Stakes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCH Biotech Ser Releases Circular Detailing Major Disposal of PHC Medical Diagnostic Centre and Premier Medicare Stakes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-30 21:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Biotech Services Holdings Limited (abbreviated as CH Biotech Ser) has published a bilingual circular dated 30 June 2026 outlining a major transaction involving the disposal of 100% of the issued share capital of two subsidiaries—PHC Medical Diagnostic Centre Limited and Premier Medicare Services Limited.</p>\n<p>The circular, now available on both the company’s website (www.cbshhk.com) and the Hong Kong Stock Exchange’s website (www.hkexnews.hk), provides shareholders with full details of the planned divestment. The transaction has been classified as “major” under the Hong Kong Listing Rules, indicating that it meets or exceeds the applicable percentage ratio thresholds for significant corporate actions.</p>\n<p>Non-registered shareholders may request hard copies of the circular free of charge by contacting the company’s Hong Kong branch share registrar, Union Registrars Limited, at Suites 3301-04, 33/F, Two Chinachem Exchange Square, 338 King’s Road, North Point, Hong Kong, or via email at 8037-corpcomm@unionregistrars.com.hk. Shareholders opting for electronic communications can provide their email addresses through their respective banking or brokerage intermediaries to receive future notices electronically.</p>\n<p>Enquiries regarding the document or the distribution arrangement can be directed to Union Registrars Limited at (+852) 2849 3399 during business hours, Monday to Friday (excluding Hong Kong public holidays).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"08037","symbol_name":"中国生物科技服务","start_time":0,"source_url":"","article_id":"1198160072","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1198160072","pubTimestamp":1782827001,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Biotech Services Holdings Limited (abbreviated as CH Biotech Ser) has published a bilingual circular dated 30 June 2026 outlining a major transaction involving the disposal of 100% of the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"08037":"中国生物科技服务"},"translate_title":"CH Biotech Ser发布通函，详细介绍PHC医疗诊断中心和Premier Medicare股权的重大处置","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08037":1},"content_text":"China Biotech Services Holdings Limited (abbreviated as CH Biotech Ser) has published a bilingual circular dated 30 June 2026 outlining a major transaction involving the disposal of 100% of the issued share capital of two subsidiaries—PHC Medical Diagnostic Centre Limited and Premier Medicare Services Limited.\nThe circular, now available on both the company’s website (www.cbshhk.com) and the Hong Kong Stock Exchange’s website (www.hkexnews.hk), provides shareholders with full details of the planned divestment. The transaction has been classified as “major” under the Hong Kong Listing Rules, indicating that it meets or exceeds the applicable percentage ratio thresholds for significant corporate actions.\nNon-registered shareholders may request hard copies of the circular free of charge by contacting the company’s Hong Kong branch share registrar, Union Registrars Limited, at Suites 3301-04, 33/F, Two Chinachem Exchange Square, 338 King’s Road, North Point, Hong Kong, or via email at 8037-corpcomm@unionregistrars.com.hk. Shareholders opting for electronic communications can provide their email addresses through their respective banking or brokerage intermediaries to receive future notices electronically.\nEnquiries regarding the document or the distribution arrangement can be directed to Union Registrars Limited at (+852) 2849 3399 during business hours, Monday to Friday (excluding Hong Kong public holidays).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}